Quotient Sciences Ltd is a drug development and manufacturing company that supports customers with the development pathway from candidate selection to commercial launch. The company offers services such as formulation development, clinical trial manufacturing, clinical pharmacology, commercial manufacturing, drug development consulting, and data sciences. It develops formulations based on the physicochemical and biopharmaceutics properties of a molecule. Formulation development services consist of formulation design, pre-formulation screening, preclinical and first-in-human (FIH) dosage forms, analytical services, and pediatric development. Quotient Sciences offers clinical trial manufacturing, testing, and certification services, and its method of building integrated good manufacturing practice (GMP) and good clinical practice (GCP) programs provides a streamlined approach to drug product supply that reflects clinical study design and timeline. Through clinical pharmacology, the company provides integrated solutions, including data management, data analysis, statistics, and medical writing. It manufactures simple to complex dosage forms for oncology therapies, orphan drugs/rare diseases, and pediatric indications.
Drug development consultants offer expertise in clinical pharmacology study designs, developability assessment for preclinical molecules, defining the target product profile (TPP), and pediatric dosage forms. Quotient Sciences helps customers with earlier interim data and interim pharmacokinetics (PK) reports for on-study dosing and formulation decisions to support decision-making.